Non-passageable viruses
US4935235A · kind A · utility
28Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 1987 |
| Grant date | Jun 19, 1990 |
| Priority date | — |
| Expiry date | Dec 1, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/223
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
What is disclosed is a protein immunoreactive with antibodies raised against HBsAg, which protein has the formula: X-S-Y, S represents a peptide residue of the hepatitis B virus S-protein, Y is OH or NH.sub.2 and X is selected from the pre-S1/pre-S2 peptide residue, the pre S2 peptide residue and a fragment of the pre-S1/pre-S2 peptide residue containing at least a 9 amino acid portion of the C-terminal sequence of pre-S2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.